PMC:7558914 / 1547-1633
Annnotations
LitCovid_Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 36-43 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
| T2 | 36-43 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 59 | 36-43 | Chemical | denotes | heparin | MESH:D006493 |
| 69 | 70-85 | Disease | denotes | thromboembolism | MESH:D013923 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T4 | 70-85 | Phenotype | denotes | thromboembolism | http://purl.obolibrary.org/obo/HP_0001907 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T13 | 0-86 | Sentence | denotes | All protocols included prophylactic heparin and therapeutic doses for thromboembolism. |